The impact of the COVID-19 pandemic on cerebrovascular disease
- 1 June 2021
- journal article
- review article
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 34 (2) , 20-27
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19New England Journal of Medicine, 2020
- Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement From Society for Neuroscience in Anesthesiology & Critical Care (SNACC)Journal of Neurosurgical Anesthesiology, 2020
- Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery OcclusionStroke, 2020
- High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous ThrombolysisCerebrovascular Diseases, 2016
- Infection and Stroke: an Update on Recent ProgressCurrent Neurology and Neuroscience Reports, 2015
- Update on Cysticercosis Epileptogenesis: the Role of the HippocampusCurrent Neurology and Neuroscience Reports, 2015
- Angiotensin-(1–7)Hypertension, 2014
- Role of HIF-1α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Acute ischaemic stroke and infection: recent and emerging conceptsThe Lancet Neurology, 2008